(E) -10-Hydroxynortriptyline
CAT:
HY-U00050
HY-U00050
804-HY-U00050-01
Size:
1 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(E) -10-Hydroxynortriptyline
Description:
(E) -10-Hydroxynortriptyline (E-10-OH-NT) is a metabolite of Nortriptyline (HY-B1417) . Nortriptyline is a tricyclic antidepressant and the main active metabolite of Amitriptyline (HY-B0527A) [1]. E-10-OH-NT is about 50% as potent as nortriptyline as an inhibitor of the neuronal uptake of norepinephrine in vitro and exhibits less anticholinergic effects in man.Product Name Alternative:
E-10-OH-NTUNSPSC:
12352005Hazard Statement:
H302Target:
Drug MetaboliteType:
Reference compoundRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
Neuroscience-NeuromodulationField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/e-10-hydroxynortriptyline.htmlPurity:
99.65Solubility:
H2O : 3.57 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : ≥ 25 mg/mLSmiles:
OC1C2=CC=CC=C2/C(C3=CC=CC=C3C1)=C/CCNCMolecular Formula:
C19H21NOMolecular Weight:
279.38Precautions:
H302References & Citations:
[1]Shimoda K, et al. The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. J Clin Psychopharmacol. 2002 Aug;22 (4) :371-8.|[2]Shimoda K, et al. Dean L. Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Biotechnology Information (US) ; 2012-2017 Mar 23.|[3]Bertilsson L, Nordin C, Otani K, et al. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects. Clin Pharmacol Ther. 1986;40 (3) :261-267. |[4]Dumont E, von Bahr C, Perry TL Jr, Bertilsson L. Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in human and rat liver microsomes. Pharmacol Toxicol. 1987;61 (5) :335-341.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedCAS Number:
[47132-16-1]
